A cross-sectional Prevalence survey of Allergic Rhinitis in Argentina

Daniel Vazquez, Iris Medina, Georgina Logusso, Gabriel Gattolin, Sergio Arias, Claudio Parisi

Resumen


In Argentina, there are few studies on the prevalence of allergic rhinitis (AR) with diverse data.

Objective: To determine the prevalence of AR in Argentina in a population between 5 and 44 years old using a self-reported symptom questionnaire to evaluate demographic characteristics and socioeconomic variables.

Methods: A national cross-sectional prevalence study to detect self-reported signs and symptoms compatible with AR was conducted. Subjects between 5 and 44 years old from urban areas were included. The information was collected using a validated telephone questionnaire.

Results: 3200 subjects were surveyed: 51.8% were females; age 5-19 y (37.6%) and 20-44 y (62.4%). 22.8% did not have health coverage. Global prevalence of AR symptoms of was 20.5%. Most frequent symptoms were sneezing (58.5%) and nasal congestion (51.4%). Overall, 44.3% of participants had family history of allergy, such as asthma, allergic rhinitis, urticaria, food allergy, drug allergy, insect sting allergy, and atopic dermatitis. AR was more frequent in females.  Regarding the distribution by age, similar percentages of AR prevalence were found among evaluated age groups: 21.1% for 5-12 y, 23.1% for the group aged 12-19 y, and 19.4% for 20-44 y (p=NS); 63.8% of subjects with symptoms of AR had no medical diagnosis.

Conclusions: Findings of this first national cross-sectional survey confirmed a high prevalence of self-reported symptoms of AR in adults and children in Argentina, especially in females. A lower prevalence was found in male adults than in other subgroups. 


Palabras clave


Allergic Rhinitis, Prevalence, Questionnaire, Epidemiology, Children, Adults

Referencias


Brozek JL, Bousquet J, Baena-Cagnani CE, et al.. Allergic Rhinitis and its Impact on Asthma (ARIA) Guidelines : 2010 Revision. J Allergy Clin Immunol 2010 ;126 :466-76.

Hansel F. Clinical and histopathologic studies of the nose and sinuses in allergy. J Allergy 1929:1:43-70.

Linneman L, Mayrga Butrón JL, Sanchez Gonzalez A, et al. ARIA México 2014. Adaptación de la Guía de Práctica Clínica ARIA 2010 para México. Metodología ADAPTE. Rev Alerg Mex 2014;61 (Supl. 1):S3-116.

Breinbauer H, Varela C, Núñez M, Ugarte S, Garfias R, Fonseca X. Encuesta de síntomas SNOT-20 para rinitis alérgica y rinosinusitis: validación en Chile. Rev Med Chile 2011; 139: 886-895.

Neffen H, Mello JF Jr, Sole D, et al. Nasal allergies in the Latin American population: results from the Allergies in Latin America survey. Allergy Asthma Proc 2010;31(Suppl 1):S9-27.

Brozek JL, Bousquet J, Agache I, et al. Allergic Rhinitis and its impact on Asthma (ARIA) guidelines-2016 revision. J Allergy Clin Immunol 2017;140:950-8.

Wheatley LM, Togias A. Allergic Rhinitis. N Engl J Med 2015; 372: 456-63.

Neffen H. How can we improve management of allergic rhinitis in Latin America? Allergy Asth Proceedings 2010; 31 (Suppl 1):S5-S7.

Asher MI, Montefort S, Bjorksten B, et al. Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjuntivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys. Lancet 2006;368:733-43.

Mancilla Hernandez E, Medina Ávalos M, Osorio Escamilla RE. Validación de un cuestionario diagnóstico de rinitis alérgica para estudios epidemiológicos. Rev Alerg México 2014;61:153-161.

Mancilla Hernandez E, Medina Ávalos M,Barnica Alvarado RH, Soto Candia D, Guerrero Venegas R, Zecua Najera Y. Prevalence of rhinitis allergic in populations of several states of Mexico.Rev Alerg Mex 2015;62:196-201.

All-Khaled N, Pearce N, Anderson HR, Ellwood P, Montefort S, Shan J. Global map of the prevalence of symptoms of rhinoconjuctivitis in children : the International Study of Asthma and Allergies in Childhood (ISAAC) Phase Three. Allergy 2009 ;64 :123-48.

Katelaris CH, Lee BW, Potter PC, et al. Prevalence and diversity of allergic rhinitis in regions of the world beynd Europe and North America. Clin Exp Allergy 2012 ;42 :186-207.

Bousquet J, Van Cauwenberge P, Khaltaev N. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 2001;108(Suppl I):S147:S334.

Zuberbier T, lotvall J, Simoens S, Subramanian SV, Church MK. Economic burden of inadequate management of allergic diseases in the European Union: a GA (2) LEN review. Allergy 2014;69:1275-9.

Yo KH, Ahn HR, Park JK, et al. Burden of respiratory disease in Korea: an observational study on allergic rhinitis, asthma, COPD and Rhinosinusitis. Allergy Asthma Immunol Res 2016;8:527-34.

Haahtela T, Valovirta E, Hannuksela M, et al. Finnish nationwide. allergy programme at mid-term change direction producting results. Finnish Med J 2015;70:2165-72.

National Institute of Statistics and Census (INDEC). Argentina National Population Census 2010. In https://www.indec.gov.ar/nivel4_default.asp?id_tema_1=2&id_tema_2=41&id_tema_3=135. Accessed on February 2nd.2017.

Vidal Diaz de Rada, Palacios Gomez JL. Comparación de las tasas de respuestas en el uso combinado de modalidades de encuestas. Rev Esp Investig Social 2013;141:159-70.

Bauchau V, Durham SR. Prevalence and rate diagnosis of allergic rhinitis in Europe. Eur Respir J 2004; 24: 758-764.

Janson C, Anto J, Burney P, et al. The European Community Respiratory Health Survey: what are the main results so far? European Community Respiratory Health Survey II. Eur Respir J 2001; 18: 598–611.

Nathan R, Meltzer EO, Derebery J, Campbell UB, Stang PE. The prevalence of nasal symptoms attributed to allergies in the United States: Findings from the burden of rhinitis in an America survey. Allergy Asthma Proc 2008;29:600–8.

Klossek J-M., Annesi-Maesano I., Pribil C., Didier A. Un tiers des adultes ont une rhinite allergique en France (enquête INSTANT). Presse Med 2009;38:1220-9.

Björkstén B, Clayton T, Ellwood P, Stewart A, Strachan D, and the ISAAC Phase Three Study Group. Worldwide time trends for symptoms of rhinitis and conjunctivitis: Phase III of the International Study of Asthma and Allergies in Childhood. Pediatr Allergy Immunol 2008; 19:110-124.

Pynnonen MA, Kim HM, Terrell JE. Validation of the Sino-Nasal Outcome Test 20 (SNOT-20) domains in non-surgical patients. Am J Rhinol Allergy 2009;23:40–5.

Nogueira SL. Control of allergic rhinitis and asthma test formal approach to the development of a measuring tool. Respir Res 2009;10:52.

Kim H. Validating childhood symptom with physician diagnosed allergic rhinitis. Ann Allergy Asthma Immunol 2012;108:228-231.

Del Río NB, Luna PJ, Berber A, et al. Factors associated with allergic rhinitis in children from northern Mexico city. J Investig Clin Immunol 2007;17:77-84.

Gonzalez Diaz SN, Del Rio Navarro BE, Pietropaolo Cienfuegos DE, et al. Factors associated with allergic rhinitis in children and adolescents from northern Mexico: International Study of Asthma and Allergies in Childhood Phase IIIB. Allergy Asthma Proceed 2010;31:e53-362




DOI: http://dx.doi.org/10.29262/ram.v65i1.543

Enlaces refback

  • No hay ningún enlace refback.


Licencia de Creative Commons
Este obra está bajo una licencia de Creative Commons Reconocimiento-NoComercial 4.0 Internacional.